[ET Net News Agency, 9 July 2024] IMMUNEONCO-B (01541) rose 20% to HK$15.48, breaking
above the 50-D SMA of HK$14.377.
It hits an intra-day high of HK$15.48, hitting an 1-month high, and an intra-day low of
HK$12.4. The total shares traded was 311,000, with a value of HK$4.42m. The active
buy/sell ratio is 60:40, with net buying turnover of HK$861,688. HSBC SEC BRO (ASIA)
accounts for greatest net responsive buying turnover of HK$190,487, with volume weighted
average price of HK$13.972. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$425,175, with volume weighted average price of
HK$14.591. The stock has risen a combined 25.9% over the past 2 consecutive trading days.
Basic Information
=================
-----------------------------------
Nominal 15.480 % Chg +20.00%
High 15.480 Low 12.400
Shares Tr 311,000 Turnover 4.42m
10-D SMA 13.530 %H.V 45.999
20-D SMA 13.958 VWAP 14.217
50-D SMA 14.377 RSI14 62.312
-----------------------------------
Status: Breaking above the 50-D SMA, hitting an 1-month high, active buy/sell ratio is
60:40, with net buying turnover of HK$861,688, rising a combined 25.9% over the past 2
consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
IMMUNEONCO-B (01541) 15.48 +20.00
GENSCRIPT BIO (01548) 8.92 +0.90
INNOVENT BIO (01801) 36.50 -3.44
JXR (01951) 2.70 -3.57
WUXI BIO (02269) 10.82 +0.37
HIGHTIDE-B (02511) 1.13 +3.67
TIGERMED (03347) 27.65 +2.79
SKB BIO-B (06990) 145.10 -1.29
AKESO (09926) 37.00 +0.95
REMEGEN (09995) 14.34 -18.34
---------------------------------------------
(ed)